# Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

> **NCT06885931** · NA · RECRUITING · sponsor: **Amber Therapeutics Ltd** · enrollment: 86 (estimated)

## Conditions studied

- Mixed Urinary Incontinence
- Stress Urinary Incontinence (SUI)
- Chronic Pelvic Pain
- Urge Urinary Incontinence

## Interventions

- **DEVICE:** Pudendal neuromodulation

## Key facts

- **NCT ID:** NCT06885931
- **Lead sponsor:** Amber Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-24
- **Primary completion:** 2027-06
- **Final completion:** 2030-01
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06885931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06885931, "Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06885931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*